Plant Stem Cells Market is Projected to Surpass Valuation of USD 855.3 million by 2032 | Cosmetics Application Contribute Over 47% Revenue Says Astute Analytica [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
North America is leading the market with highest market share. New Delhi, April 15, 2024 (GLOBE NEWSWIRE) -- According to the latest research by Astute Analytica, the global plant stem cells market is projected to reach a valuation of US$ 855.3 million by 2032, up from US$ 396.1 million in 2023, at a CAGR of 8.93% during the forecast period 2024–2032. Request Free Sample Pages @ https://www.astuteanalytica.com/request-sample/plant-stem-cells-market The plant stem cells market is witnessing significant growth driven by diverse applications and ongoing research into their remarkable properties. One key driver is the cosmetics industry, where products containing plant stem cell extracts demonstrate powerful anti-aging properties, as exemplified by the success of PhytoCellTech Malus Domestica (apple stem cell extract). Intensive research efforts are revealing groundbreaking insights into plant stem cell biology. Scientists are intrigued by the ability of plant stem cells to easily r
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect [Yahoo! Finance]Yahoo! Finance
- mRNA Is Promising A Breakthrough In Fighting Cancer [Yahoo! Finance]Yahoo! Finance
- Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative [Yahoo! Finance]Yahoo! Finance
- Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/22/24 - Beat
MRNA
Sec Filings
- 4/26/24 - Form 4
- 4/24/24 - Form 144
- 4/19/24 - Form 4
- MRNA's page on the SEC website